The role of inflammatory mediators in renal vascular remodeling in patients with arterial hypertension
Abstract
About the Authors
E. S. KrutikovRussian Federation
S. I. Chistyakova
Russian Federation
References
1. Гринштейн Ю.Н. Гипертензивная нефропатия: встречаемость и диагностические маркеры / Ю.Н. Гринштейн, В.В. Шабалин, А.А. Косинова // Российские медицинские вести. - 2011. - № 4. - С. 30-32.
2. Диагностика и лечение болезней почек / Н.А. Мухин, Н.Е. Тареева, Е.М. Шилов, Л.В. Козловская. - М.: ГЭОТАР-медиа, 2011. - 384 с.
3. Николаев А.Ю. Анализ ведущих факторов прогрессирования хронической болезни почек // Журнал «Нефрология и диализ». - 2010. - Т. 13. № 4. - С. 40-44.
4. Levey A. Chronic kidney disease / A. Levey, J. Coresh // The lancet. - 2012. - Vol. 379. № 9811. - P. 165-180.
5. Brent E. Wisse. The inflammatory syndrome: the role of adipas tissue cytokines in metabolic disorders linked to obesity // Journal of the American society of nephrology. - 2012. - № 15. -Р. 2792-2800.
6. Ejerblad E. Obesity and risk for chronic renal failure // Journal of the American society of nephrology. - 2007. -№ 17. - Р. 1695-1702.
7. Gupta J., Mitra N. Association between albuminuria, kidney function, and inflammatory biomarker profile in chronic kidney disease // Clinical journal of the american society of nephrology. -2012. - Vol. 7. № 12. - P. 38-42.
8. Hall M.E., Warg Z. Obesity, hypertension and chronic kidney disease // International journal of nephrology and renovascular disease. - 2014. Vol. 7. - P. 75-88.
9. Krzyszotof Narkiewiez. Obesity and hypertension - the issue is more complex than we thought // Nephrology dialysis transplantation. - 2009. - Vol. 21. - P. 264-267.
10. Lam C. Inflammation cytokines and chemokines in chronic kidney disease // The electronic journal of the international federation of dinical chemistry and laboratory medicine. - 2009. - Vol. 20. № 4. - Р. 24-28.
11. Locatelli F., Pozzoni P. Renal manifestations in the metabolic syndrome // Journal of the american society of nephrology. -2012. - № 17. - Р. 81-85.
12. Murea M. Essential hypertension and risk nephropathy: a reappraisal / M. Murea, B.I. Freedman // Current opinion in nephrology and hypertension. - 2010. - № 19. - Р. 235-241.
13. Roubicek T., Bartlova M. Increased production of pro-inflammatory cytokines in adipose tissue of the patient with end-stage renal disease // Nutrition journal. - 2009. - № 25. -Р. 7-8.
14. Shalomai G. Assessment of target organ damage in the evaluation and follow-up of hypertensive patients / G. Shalomai, G. Grassi, et al. // The journal of clinical hypertension. - 2013. -Vol. 15. № 10. - P. 742-747.
15. Saxena A.K., Chopra R. Renal risk of an emerging epidemic of obesity: the role of adipocyte-derived factors // Nephrology, dialysis and transplantation. - 2011. - № 33. - Р. 11-20.
16. Spoto B., Leonardis D. Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease patient // Nutrition, metabolism and cardiovascular disease journal. - 2012. - Vol. 22. № 11. -P. 81-88.
17. Verani R.R., Grone E.F. The role of lipids in nephrosclerosis and glomerulosclerosis // Atherosclerosis. - 2009. - № 107. -Р. 1-13.
18. Zoccale C., Mallamaci F. Adipose tissue a source of inflammatory cytokines in health and disease: focus on end-stage renal disease // Kidney International. - 2013. - Vol. 63. № 4. -P. 65-68.
Review
For citations:
Krutikov E.S., Chistyakova S.I. The role of inflammatory mediators in renal vascular remodeling in patients with arterial hypertension. Kuban Scientific Medical Bulletin. 2014;(5):66-71. (In Russ.)